CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,128 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 3,803 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 10,604 shares (to pay taxes)
- DEF 14A Proxy Proxy Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Executive or director change · Regulation FD disclosure
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 3,012 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 2,995 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,128 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 3,803 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 10,604 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF COMMERCIAL OFFICER gave up 54,695 shares (to pay taxes)
- 4 Shares withheld for taxes SVP and CFO gave up 54,450 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 56,810 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel gave up 67,544 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 187,704 shares (to pay taxes)
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Scientific Officer sold 217,728 shares at an average $8.06 ($1,754,134)
Page 20 of 77 · 1,527 filings